PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Operating Income: Rp162,506 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:DVLA PT Darya-Varia Laboratoria Tbk ISX:DVLA
70 GF Score
Price Rp1,580.00
GF Value Rp1,862.94
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is PT Darya-Varia Laboratoria Tbk Operating Income?

PT Darya-Varia Laboratoria Tbk ISX:DVLA 70 Operating Income is Rp162,506 Mil as of Jun. 2026. GuruFocus rates ISX:DVLA with a GF Score™ of 70/100 and a GF Value™ of Rp1,862.94 (Modestly Undervalued). The stock has 4 warning signs investors should review.

PT Darya-Varia Laboratoria Tbk's Operating Income for the three months ended in Jun. 2026 was Rp45,780 Mil. Its Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 was Rp162,506 Mil.

Operating Margin % is calculated as Operating Income divided by its Revenue. PT Darya-Varia Laboratoria Tbk's Operating Income for the three months ended in Jun. 2026 was Rp45,780 Mil. PT Darya-Varia Laboratoria Tbk's Revenue for the three months ended in Jun. 2026 was Rp613,799 Mil. Therefore, PT Darya-Varia Laboratoria Tbk's Operating Margin % for the quarter that ended in Jun. 2026 was 7.46%.

Warning Sign:

PT Darya-Varia Laboratoria Tbk operating margin has been in a 5-year decline. The average rate of decline per year is -3.1%.

PT Darya-Varia Laboratoria Tbk's 5-Year average Growth Rate for Operating Margin % was -3.10% per year.

Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. PT Darya-Varia Laboratoria Tbk's annualized ROC % for the quarter that ended in Jun. 2026 was 7.42%. PT Darya-Varia Laboratoria Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 20.16%.


PT Darya-Varia Laboratoria Tbk  (ISX:DVLA) Operating Income Explanation

1. Operating Income or EBIT is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

PT Darya-Varia Laboratoria Tbk's annualized ROC % for the quarter that ended in Jun. 2026 is calculated as:

ROC % (Q: Jun. 2026 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Mar. 2026 ) + Invested Capital (Q: Jun. 2026 ))/ count )
=183118.572 * ( 1 - 27.17% )/( (1821560.657 + 1775208.581)/ 2 )
=133365.2559876/1798384.619
=7.42 %

where

Invested Capital(Q: Mar. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2516208.197 - 227582.795 - ( 467064.745 - max(0, 780931.446 - 1831261.822+467064.745))
=1821560.657

Invested Capital(Q: Jun. 2026 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=2606430.632 - 360200.753 - ( 471021.298 - max(0, 894814.238 - 1927122.647+471021.298))
=1775208.581

Note: The Operating Income data used here is four times the quarterly (Jun. 2026) data.

2. Joel Greenblatt's definition of Return on Capital:

PT Darya-Varia Laboratoria Tbk's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 is calculated as:

ROC (Joel Greenblatt) %(Q: Jun. 2026 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Mar. 2026  Q: Jun. 2026
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=210963.244/( ( (496081.944 + max(561400.899, 0)) + (497777.129 + max(537558.487, 0)) )/ 2 )
=210963.244/( ( 1057482.843 + 1035335.616 )/ 2 )
=210963.244/1046409.2295
=20.16 %

where Working Capital is:

Working Capital(Q: Mar. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(818420.679 + 443399.043 + 80349.273) - (227582.795 + 0 + 553185.301)
=561400.899

Working Capital(Q: Jun. 2026 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(833577.19 + 542951.987 + 55724.154) - (360200.753 + 0 + 534494.091)
=537558.487

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.

3. Operating Income is also linked to Operating Margin %:

PT Darya-Varia Laboratoria Tbk's Operating Margin % for the quarter that ended in Jun. 2026 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=45779.643/613799.198
=7.46 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Operating Income growth rate using Operating Income per share data.


Be Aware

Compared with a company's EBITDA margin, Operating Margin can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).

If a company is facing competition, its Operating Margin may decline. Often the Operating Margin declines well before the company's revenue or even profit decline. Therefore, Operating Margin is a very important indicator of whether the company is facing problems.

For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokia's Operating Margin had already been in decline since 2002, although its earnings per share were still rising. Investors who paid attention to Operating Margin would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).

Therefore, Operating Margin is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.


PT Darya-Varia Laboratoria Tbk Operating Income Related Terms


PT Darya-Varia Laboratoria Tbk Operating Income Historical Data

* Premium members only.

The historical data trend for PT Darya-Varia Laboratoria Tbk's Operating Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Darya-Varia Laboratoria Tbk Operating Income Chart

PT Darya-Varia Laboratoria Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Operating Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 188,868.51 174,971.94 177,309.14 196,523.12 205,867.11

PT Darya-Varia Laboratoria Tbk Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Operating Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 56,606.37 52,037.96 -4,193.42 68,882.16 45,779.64
ISX:DVLA
70GF Score
PT Darya-Varia Laboratoria Tbk ISX:DVLA
Operating Income is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Darya-Varia Laboratoria Tbk Operating Income Calculation

Operating Income, is the profit a company earned through operations. All expenses, including cash expenses such as cost of goods sold (COGS), research & development, wages, and non-cash expenses, such as depreciation, depletion and amortization, have been deducted from the sales.

Operating Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp162,506 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Operating Income →
What does a Operating Income of Rp162,506 Mil mean?
PT Darya-Varia Laboratoria Tbk (ISX:DVLA) has a Operating Income of Rp162,506 Mil as of Jun. 2026. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors.
Is PT Darya-Varia Laboratoria Tbk's Operating Income too high?
PT Darya-Varia Laboratoria Tbk's current Operating Income is Rp162,506 Mil. Overall, PT Darya-Varia Laboratoria Tbk has a GF Score™ of 70/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Darya-Varia Laboratoria Tbk's Operating Income compare to ZTS and UTHR?
PT Darya-Varia Laboratoria Tbk's Operating Income of Rp162,506 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Income for a Drug Manufacturers company?
A good Operating Income depends on the Drug Manufacturers industry context. However, Operating Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Income mean?
A high Operating Income can signal that a stock is expensive relative to its fundamentals. Operating Income equals sales less all operating expenses. It is linked to EBIT. View historical data on PT Darya-Varia Laboratoria Tbk and its competitors. PT Darya-Varia Laboratoria Tbk's current Operating Income is Rp162,506 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Darya-Varia Laboratoria Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk (ISX:DVLA) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp1,862.94, compared to a current price of Rp1,580.00 — trading 15.2% below its estimated fair value. The current Operating Income is Rp162,506 Mil. PT Darya-Varia Laboratoria Tbk's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Income calculated?
Operating Income is calculated from a company's financial statements. For PT Darya-Varia Laboratoria Tbk (ISX:DVLA), the current Operating Income is Rp162,506 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Darya-Varia Laboratoria Tbk (ISX:DVLA) Overvalued in 2026?

Based on GuruFocus' analysis, PT Darya-Varia Laboratoria Tbk stock appears to be undervalued. The current stock price of Rp1,580.00 is trading 15.2% below its estimated GF Value™ of Rp1,862.94. GuruFocus considers PT Darya-Varia Laboratoria Tbk to be Modestly Undervalued.

Key valuation signals for ISX:DVLA:

  • Operating Income: Rp162,506 Mil
  • GF Value™: Rp1,862.94 vs. price of Rp1,580.00 (15.2% below fair value)
  • GF Score™: 70/100 with 4 warning signs

No single metric tells the full story. See the ISX:DVLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PT Darya-Varia Laboratoria Tbk Business Description

Address Jalan. R.A. Kartini Kav. 8, 18th-19th Floor, South Quarter, Tower C, Jakarta, IDN, 12430
PT Darya-Varia Laboratoria Tbk (Darya-Varia) is operating in the pharmaceutical industry. It is engaged in the manufacture and trade of pharmaceutical products, human, traditional medicines, pharmaceutical materials, raw materials for traditional medicines, inorganic base chemicals, organic base chemicals, equipment for surgery, medical and dental care, and equipment, orthopedic equipment, prosthetic, eyeglasses, laboratory and health equipment from glass, cosmetics, wholesaler of pharmaceutical, traditional medicine, chemical base materials, laboratory testing services, periodic inspection services, and many more activities. Its business segments include: prescription drugs; consumer health products, which derives key revenue; export and toll manufacturing services; and services.
70GF Score

Get the complete analysis for ISX:DVLA

Operating Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp1,580.00
Price
Rp1,862.94
GF Value